• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
66.2311355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
59.06
4341.23
EPS(TTM)
Face Value()
Div & Yield %
7.33
1
0.02
 

satani bearings ltd
Kalind consolidated net profit rises 6718.18% in the March 2026 quarter
Apr 28,2026
Net profit of Kalind rose 6718.18% to Rs 15.00 crore in the quarter ended March 2026 as against Rs 0.22 crore during the previous quarter ended March 2025. Sales reported to Rs 33.11 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 27.23 crore in the year ended March 2026 as against net loss of Rs 0.15 crore during the previous year ended March 2025. Sales reported to Rs 79.85 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales33.110 0 79.850 0
OPM %54.420 -48.530 -
PBDT21.710.02 108450 41.56-0.35 LP
PBT19.950.02 99650 36.35-0.48 LP
NP15.000.22 6718 27.23-0.15 LP